ライフサイエンスコーパス: necrotizing pancreatitis

1 gastrointestinal tract perforation, 21 acute necrotizing pancreatitis).

2 ea of intra-parenchymal necrosis, indicating necrotizing pancreatitis.

3 The injection of cerulein resulted in acute necrotizing pancreatitis.

4 g catheter drainage for (suspected) infected necrotizing pancreatitis.

5 imicrobial use in patients with severe acute necrotizing pancreatitis.

6 ys (range, 20-300 days) after onset of acute necrotizing pancreatitis.

7 nd distant organ injury in a murine model of necrotizing pancreatitis.

8 terial or antifungal agents in patients with necrotizing pancreatitis.

9 lied to the entire spectrum of patients with necrotizing pancreatitis.

10 nduced multisystem organ failure or to acute necrotizing pancreatitis.

11 1, are central events in the pathogenesis of necrotizing pancreatitis.

12 s in the pancreas and at 12 hours in lung in necrotizing pancreatitis.

13 for success of catheter drainage in infected necrotizing pancreatitis.

14 entral event in the progression to fulminant necrotizing pancreatitis.

15 ungs from rats with mild edematous or severe necrotizing pancreatitis.

16 e occurred in only one half of patients with necrotizing pancreatitis.

17 o detect the presence of sterile or infected necrotizing pancreatitis.

18 lure; this makes the pancreas susceptible to necrotizing pancreatitis.

19 d patients with clinically severe, confirmed necrotizing pancreatitis: 50 received meropenem and 50 r

20 ed successfully to manage most patients with necrotizing pancreatitis, although some will eventually

21 Patients had signs of infected necrotizing pancreatitis and an indication for intervent

22 antibiotics can reduce mortality from acute necrotizing pancreatitis (ANP).

23 s responsible for the progression of mild to necrotizing pancreatitis are poorly understood.

24 At least 30% of patients with infected necrotizing pancreatitis are successfully treated with c

25 Between 1997 and 2013, patients with necrotizing pancreatitis at the Liverpool Pancreas Cente

26 who underwent uniform surgical treatment for necrotizing pancreatitis at the Massachusetts General Ho

27 into interstitial edematous pancreatitis and necrotizing pancreatitis, (c) distinguish an early phase

28 In patients with sterile acute necrotizing pancreatitis, conservative nonsurgical manag

29 Mortality after debridement for necrotizing pancreatitis continues to be inordinately hi

30 In patients with infected necrotizing pancreatitis, endoscopic necrosectomy reduce

31 otics should be given only in the setting of necrotizing pancreatitis, especially if patients are rec

32 is study was to examine a rat model of acute necrotizing pancreatitis for changes in NGF expression.

33 Patients with necrotizing pancreatitis from May 1992 to January 1996 w

34 n vivo in the course of taurocholate-induced necrotizing pancreatitis in rats and in vitro in rat pan

35 athologic changes during the course of acute necrotizing pancreatitis in rats induced by the intraper

36 aurocholate into the pancreatic duct induced necrotizing pancreatitis in the head of pancreas and lig

37 The development of acute necrotizing pancreatitis in this model leads to a signif

38 walled-off pancreatic necrosis (WOPN) after necrotizing pancreatitis is limited.

39 In patients with severe, necrotizing pancreatitis, it is common to administer ear

40 everity of illness, studies of patients with necrotizing pancreatitis must stratify for organ failure

41 Severe necrotizing pancreatitis occurs in young female mice fed

42 course of the disease for all patients with necrotizing pancreatitis, regardless of the status of in

43 Most patients with infected necrotizing pancreatitis require necrosectomy.

44 There were 99 (9%) patients with necrotizing pancreatitis treated, with an overall death

45 ollected from inbred rats after induction of necrotizing pancreatitis; trypsinogen activation peptide

46 8 sterile and 3 infected) after severe acute necrotizing pancreatitis underwent attempted endoscopic

47 Acute necrotizing pancreatitis was induced by i.p. administrat

48 Necrotizing pancreatitis was induced in transgenic (-/-)

49 criteria, patients with acute cholangitis or necrotizing pancreatitis were excluded.

50 November 1996, 64 consecutive patients with necrotizing pancreatitis were treated with necrosectomy

51 Retrospective review of 167 patients with necrotizing pancreatitis who required intervention and w

52 Treatment of severe necrotizing pancreatitis with monoclonal antibodies agai

53 Mice lacking NOS have a severe, necrotizing pancreatitis, with elevated pancreatic enzym